March 26, 2020
Pear Therapeutics announced this morning that Somryst, its prescription digital therapeutic for adults with chronic insomnia, has received marketing authorization from the FDA.
The treatment provides cognitive behavioral therapy for insomnia (CBTi) alongside personalized, algorithm-generated sleep restriction recommendations. The digital therapeutic was reviewed through the agency's 510(k)...
March 25, 2020
A Dubai-based entrepreneur has backed a British biotech research company currently working on an affordable vaccine to protect against COVID-19.
Khurram Shroff, chairman of the UAE’s IBC Group, has donated a total of AED 5 million ($1.36m) to Vaxbio, also joining the company as a strategic advisor to assist with the development and communication of its corporate initiatives.
Vaxbio, a research...
March 17, 2020
Yesterday a new digital pharmacy launched, dubbed Genius Rx. The new platform will include an artificial intelligence enabled patient engagement tool, which aims to make the experience more personalized, as well as a smart pricing function.
In part, the company said this is an effort to rebrand and automate Mailmyprescriptions.com, which will now be rolled into its pharmacy-as-a-service platform...
February 24, 2020
A full transcript of STARS-ADHD — the pivotal trial of Akili Interactive’s video game-like pediatric attention deficit treatment — has been published in The Lancet Digital Health journal, providing onlookers a clear view of data fueling the digital therapeutic company’s pending FDA submission.
The writeup echoes topline findings first unveiled by the company in December 2017: compared to a...
February 21, 2020
Health research studies conducted using health research apps are capable of recruiting a large number of participants, but these efforts often see early dropouts and do not enrolls samples representative of the larger population, according to a study published this week in NPJ Digital Medicine.
The investigation, headed by the science research-focused nonprofit Sage Bionetworks, reviewed user...
February 21, 2020
After partnering with LIVI and launching the Reboot Quiz, Boots UK has announced that it is piloting the Doctor Care Anywhere (DCA) ePrescription service in 20 stores across central London.
Its introduction means that patients will be able to have their prescriptions sent electronically to a Boots pharmacy “within moments” of their consultation.
DCA, which is registered with the Care Quality...
January 30, 2020
Alto, a digital pharmacy and drug delivery company, will announce next week the close of a $250 million Series D funding round headed by SoftBank’s Vision Fund 2, Reuters and others reported this morning. Greenoaks Capital, Jackson Square Ventures and other prior backers also participated in the round.
This round would bring Alto’s total raise to more than $350 million, and its valuation to more...